Guillermo A. Morales, Ph.D.:

Dr. Morales received his BS in Industrial Chemistry from U.A.N.L. in Monterrey, Mexico, in 1989. Then he went to LSU where he received his Ph.D. in Organic Chemistry in the Spring of 1995 under the direction of Dr. Mark L. McLaughlin. Dr. Morales then immediately went to PostDoc in the area of Combinatorial Chemistry at DuPont-Merck Pharmaceuticals (formerly DuPont-Pharmaceuticals Company, now Bristol-Myers Squibb) under the direction of Dr. William F. DeGrado. Then in 1997 Dr. Morales joined Guilford Pharmaceuticals (now MGI Pharma) where he played a key role in setting up their combinatorial chemistry program. In August 2000 Dr. Morales joined Dr. Barry A. Bunin to co-found Libraria Inc. (formerly Sertanty Inc. and now Eidogen-Sertanty). In March 2003 Dr. Morales began his consulting career in drug discovery, medicinal chemistry, combinatorial/parallel synthesis, and cheminformatics. In August 2004 Dr. Morales joined Telik Inc. to ramp up the parallel medicinal chemistry efforts. In March of 2007 Dr. Morales joined Semafore Pharmaceuticals Inc. as Director of Chemistry to head chemistry efforts in the areas of PI3K, PTEN and p53 for cancer research.

As of June 2007, Dr. Morales is the Editor-in-Chief of the scientific journal Molecular Diversity.

Current Status: Director of Chemistry at Semafore Pharmaceuticals Inc. and drug discovery consultant.

This website is Dr. Morales' attempt to assist the scientific community with the latest technologies and advances in the fast evolving fields of combinatorial chemistry and high-throughput synthesis.